


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+12.29%
+1.82%
+0.72%
-0.86%
+10.34%
HIMS
Hims & Hers
$32.95
Strengths

Earnings are forecast to grow

Expands stock buyback program

Upgraded on attractively valued

Investors confidence is positive
Technical Indicators

5+ Days Down
HIMS Price Performance
$40.02 (-17.67%)
$57.97 (-43.16%)
$49.98 (-34.07%)
$27.85 (+18.31%)
HIMS has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

HIMS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Has a weak balance sheet

Revenue increase YoY

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
HIMS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
HIMS Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels
What is HIMS current stock price?
What are HIMS stock strengths?
What is HIMS Risk Level?
What is HIMS market cap and volume?
What is HIMS current Stock IQ?
Should I buy HIMS stock right now?
Is HIMS a Strong Buy right now?
What does a 'Strong Buy' rating mean for HIMS?
What does a 'Strong Sell' rating mean for HIMS?
What factors influence HIMS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+12.29%
+1.82%
+0.72%
-0.86%
+10.34%
HIMS
Hims & Hers
Current Price
$32.95
Stock Insights
Strengths

Earnings are forecast to grow

Expands stock buyback program

Upgraded on attractively valued

Investors confidence is positive
Technical Indicators

5+ Days Down

HIMS Price Performance
$40.02 (-17.67%)
$57.97 (-43.16%)
$49.98 (-34.07%)
$27.85 (+18.31%)
HIMS Analysts Opinion
HIMS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Has a weak balance sheet

Revenue increase YoY

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
HIMS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
HIMS Street Sentiment is bullish and have negative views on the near-term outlook
HIMS has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
HIMS Stock IQ
HIMS Latest Analysis
Unpacking the Latest Options Trading Trends in Hims & Hers Health. Investors with a lot of money to spend have taken a bearish stance on HIMS).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with HIMS it often means somebody knows something is about to happen.So how do we know what th
Wed Dec 31, 2025
Hims & Hers Health Inc. (HIMS) Dips More Than Broader Market: What You Should Know. The latest trading day saw Hims & Hers Health Inc. (HIMS) settling at $33.05 representing a -3.09% change from its previous close.
Tue Dec 30, 2025
GXAI: Initiation of Gaxos.AI. By Gaxos.AI (NASDAQ:GXAI) is primarily comprised of two businesses: RNK Health and Gaxos Labs. The former sells peptides wellness health and GLP-1 products through eCommerce and accounted for 92% of sales in the first nine months of 2025 and the latter has web and mobile-based Generative AI subscription tools and services.Both businesses are in the start-up phase having only been launched last fall with RNK Health generating most of the revenues. Based on the last r
Mon Dec 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HIMS Stock trends
HIMS Stock performance
HIMS Stock analysis
HIMS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.